202 related articles for article (PubMed ID: 27156205)
1. Malignant pleural mesothelioma in a young adult with no known exposure to asbestos.
Espinosa Muñoz E; Ramírez Ocaña D; Gutiérrez Cardo AL
Arch Bronconeumol; 2016 Dec; 52(12):615-616. PubMed ID: 27156205
[No Abstract] [Full Text] [Related]
2. Muscle Involvement in Long-term Malignant Pleural Mesothelioma.
Cruz Castellanos P; González Merino T; de Castro Carpeño J
Arch Bronconeumol (Engl Ed); 2018 May; 54(5):284-285. PubMed ID: 29132764
[No Abstract] [Full Text] [Related]
3. Prostate-specific membrane antigen avidity on positron emission tomography scan in malignant pleural mesothelioma.
Ekanayake SKDM; Yang IA; Godbolt DB; Windsor MN; Henderson D; Kyle S; Sterling D; Lee JC
ANZ J Surg; 2019 Sep; 89(9):E406-E407. PubMed ID: 29873168
[No Abstract] [Full Text] [Related]
4. Metabolic response assessment with 18F-FDG-PET/CT is superior to modified RECIST for the evaluation of response to platinum-based doublet chemotherapy in malignant pleural mesothelioma.
Kanemura S; Kuribayashi K; Funaguchi N; Shibata E; Mikami K; Doi H; Kitajima K; Hasegawa S; Nakano T
Eur J Radiol; 2017 Jan; 86():92-98. PubMed ID: 28027772
[TBL] [Abstract][Full Text] [Related]
5. 99mTc-HDP Bone Scintigraphy, SPECT/CT, and 18F-FDG PET/CT Diagnosis Imaging of Incidental Pleural Mesothelioma in a Patient With Biochemical Recurrences of Prostate Cancer: Is it Really a Coincidence?
Fernández-Rodríguez P; Martín-Marcuartu JJ; Acevedo Báñez I; Masero Carretero JM; Jiménez-Hoyuela García JM
Clin Nucl Med; 2020 Mar; 45(3):e148-e150. PubMed ID: 31977466
[TBL] [Abstract][Full Text] [Related]
6. Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study.
van Zandwijk N; Pavlakis N; Kao SC; Linton A; Boyer MJ; Clarke S; Huynh Y; Chrzanowska A; Fulham MJ; Bailey DL; Cooper WA; Kritharides L; Ridley L; Pattison ST; MacDiarmid J; Brahmbhatt H; Reid G
Lancet Oncol; 2017 Oct; 18(10):1386-1396. PubMed ID: 28870611
[TBL] [Abstract][Full Text] [Related]
7. Malignant pleural mesothelioma: two cases in first degree relatives.
Wilkins A; Popat S; Hughes S; O'Brien M
Lung Cancer; 2007 Sep; 57(3):407-9. PubMed ID: 17400330
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic Imaging and workup of Malignant Pleural Mesothelioma.
Cardinale L; Ardissone F; Gned D; Sverzellati N; Piacibello E; Veltri A
Acta Biomed; 2017 Aug; 88(2):134-142. PubMed ID: 28845826
[TBL] [Abstract][Full Text] [Related]
9. [Usefulness of 18F-FDG PET-CT in the presurgical assessment of malignant pleural mesothelioma treated with neoadjuvant chemotherapy].
Orcajo Rincón J; Alonso Farto JC; Rotger Regi A; Hernández Pérez R; Hualde AM; Pérez Aradas V
Rev Esp Med Nucl; 2011; 30(5):307-10. PubMed ID: 21641092
[TBL] [Abstract][Full Text] [Related]
10. Metabolic response to pegylated arginine deiminase in mesothelioma with promoter methylation of argininosuccinate synthetase.
Szlosarek PW; Luong P; Phillips MM; Baccarini M; Stephen E; Szyszko T; Sheaff MT; Avril N
J Clin Oncol; 2013 Mar; 31(7):e111-3. PubMed ID: 23319692
[No Abstract] [Full Text] [Related]
11. Shoulder ring complaints as a rare first symptom of malignant pleural mesothelioma.
Lorkowski J; Grzegorowska O; Kotela A; Weryński W; Kotela I
Adv Exp Med Biol; 2015; 852():5-10. PubMed ID: 25724794
[TBL] [Abstract][Full Text] [Related]
12. Optimization of response classification criteria for patients with malignant pleural mesothelioma, a validation study.
Buikhuisen WA; Qayyum F; Armato SG; Baas P
Lung Cancer; 2019 Dec; 138():139-140. PubMed ID: 31733933
[No Abstract] [Full Text] [Related]
13. Mesothelioma With a Large Prevascular Lymph Node: N1 Involvement or Something Different?
Berzenji L; Van Schil PE; Snoeckx A; Hertoghs M; Carp L
Ann Thorac Surg; 2018 May; 105(5):e189-e191. PubMed ID: 29355487
[TBL] [Abstract][Full Text] [Related]
14. Present and future roles of FDG-PET/CT imaging in the management of malignant pleural mesothelioma.
Kitajima K; Doi H; Kuribayashi K
Jpn J Radiol; 2016 Aug; 34(8):537-47. PubMed ID: 27222020
[TBL] [Abstract][Full Text] [Related]
15. Combination of cisplatin and lurbinectedin as palliative chemotherapy in progressive malignant pleural mesothelioma: Report of two cases.
Metaxas Y; Cathomas R; Mark M; von Moos R
Lung Cancer; 2016 Dec; 102():136-138. PubMed ID: 27440191
[TBL] [Abstract][Full Text] [Related]
16. [Malignant Pleural Mesothelioma with Excessive Inflammation and High Level of Interleukin 6 - A Case Report].
Miura T; Iida S; Igaki T; Shiobara H; Matsumoto R; Mitachi K; Miyakawa T; Ohata Y; Saitou K; Irie T; Yamazaki S
Gan To Kagaku Ryoho; 2016 Nov; 43(12):2106-2108. PubMed ID: 28133237
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of metabolic response by positron emission tomography after neoadjuvant chemotherapy for resectable malignant pleural mesothelioma.
Tsutani Y; Takuwa T; Miyata Y; Fukuoka K; Hasegawa S; Nakano T; Okada M
Ann Oncol; 2013 Apr; 24(4):1005-10. PubMed ID: 23136224
[TBL] [Abstract][Full Text] [Related]
18. Screening for malignant pleural mesothelioma and lung cancer in individuals with a history of asbestos exposure.
Roberts HC; Patsios DA; Paul NS; DePerrot M; Teel W; Bayanati H; Shepherd F; Johnston MR
J Thorac Oncol; 2009 May; 4(5):620-8. PubMed ID: 19357540
[TBL] [Abstract][Full Text] [Related]
19. Localized malignant pleural mesothelioma of the interlobar fissure mimicking a lung cancer.
Ciriaco P; Viscardi S; Filipello F; Negri G
Interact Cardiovasc Thorac Surg; 2022 Mar; 34(4):700-702. PubMed ID: 34792143
[TBL] [Abstract][Full Text] [Related]
20. [Malignant mesothelioma risk factors: experience in the General Hospital of Mexico].
Hernández-Solís A; Garcia-Hernández C; Reding-Bernal A; Cruz-Ortiz H; Cicero-Sabido R
Cir Cir; 2013; 81(4):312-6. PubMed ID: 25063896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
